CN Patent
CN110237233B — 一种含有环孢素的眼用药物组合物、其制备方法及用途
Assigned to Shenyang Xingqi Pharmaceutical Co Ltd · Expires 2021-01-15 · 5y expired
What this patent protects
本发明属于药物和制剂领域,涉及一种含有环孢素的眼用药物组合物、其制备方法及用途。具体地,本发明涉及一种含有环孢素的眼用药物组合物,按照重量百分比计算,其包含:环孢素0.01%-0.5%,油相0.2%-0.9%,表面活性剂0.1%-5.0%。本发明的眼用溶液能够稳定保存24个月,稳定性良好,杂质较低。
USPTO Abstract
本发明属于药物和制剂领域,涉及一种含有环孢素的眼用药物组合物、其制备方法及用途。具体地,本发明涉及一种含有环孢素的眼用药物组合物,按照重量百分比计算,其包含:环孢素0.01%-0.5%,油相0.2%-0.9%,表面活性剂0.1%-5.0%。本发明的眼用溶液能够稳定保存24个月,稳定性良好,杂质较低。
Drugs covered by this patent
- Sandimmune (cyclosporine) · Novartis AG (originally Sandoz)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.